title: Translating the molecular message of triple-negative breast cancer into targeted therapy.
abstract: Triple-negative breast cancer (TNBC) has a poor prognosis with limited treatment options. Genomic analysis of TNBCs offers the opportunity to decode TNBC into biologically relevant subtypes with unique molecular targets. With further research, these findings may be translated into effective targeted therapeutic options.
authors.affiliation: Division of Hematology-Oncology, University of California San Francisco, San Francisco, California.
authors.forename: Neelima
authors.initials: N
authors.lastname: Vidula
authors.affiliation: University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. hrugo@medicine.ucsf.edu.
authors.forename: Hope S
authors.initials: HS
authors.lastname: Rugo
mesh_terms: D005260:Female; D006801:Humans; D059467:Transcriptome; D064726:Triple Negative Breast Neoplasms / Q000145:classification* / Q000235:genetics* / Q000401:mortality*